pmc logo image
Logo of aacAntimicrob Agents Chemother SubscriptionsAntimicrob Agents Chemother Web Site

Formats:

Antimicrob Agents Chemother. 1986 July; 30(1): 196–198.
PMCID: PMC176467
Comparison of foscarnet cream, acyclovir cream, and acyclovir ointment in the topical treatment of experimental cutaneous herpes simplex virus type 1 infection.
S L Spruance, D J Freeman, and N V Sheth
Abstract
Topical foscarnet (PFA) and acyclovir (ACV) were compared in the dorsal cutaneous guinea pig model of herpes simplex virus type 1 infection. The relative order of efficacy was PFA cream greater than ACV cream greater than ACV ointment. In vitro studies demonstrated that PFA and ACV formulated in cream vehicles penetrated through guinea pig skin 7- to 10-fold faster than did ACV in ointment.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (565K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • De Clercq E, Descamps J, Verhelst G, Walker RT, Jones AS, Torrence PF, Shugar D. Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. J Infect Dis. 1980 May;141(5):563–574. [PubMed]
  • Ericson AC, Larsson A, Aoki FY, Yisak WA, Johansson NG, Oberg B, Datema R. Antiherpes effects and pharmacokinetic properties of 9-(4-hydroxybutyl) guanine and the (R) and (S) enantiomers of 9-(3,4-dihydroxybutyl)guanine. Antimicrob Agents Chemother. 1985 May;27(5):753–759. [PubMed]
  • Fiddian AP, Kinghorn GR, Goldmeier D, Rees E, Rodin P, Thin RN, de Konig GA. Topical acyclovir in the treatment of genital herpes: a comparison with systemic therapy. J Antimicrob Chemother. 1983 Sep;12 Suppl B:67–77. [PubMed]
  • Fiddian AP, Yeo JM, Stubbings R, Dean D. Successful treatment of herpes labialis with topical acyclovir. Br Med J (Clin Res Ed). 1983 May 28;286(6379):1699–1701. [PubMed]
  • Freeman DJ, Sacks SL, De Clercq E, Spruance SL. Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2'-deoxyuridine cream. Antiviral Res. 1985 Jun;5(3):169–177. [PubMed]
  • Freeman DJ, Sheth NV, Spruance SL. Failure of topical acyclovir in ointment to penetrate human skin. Antimicrob Agents Chemother. 1986 May;29(5):730–732. [PubMed]
  • Freeman DJ, Spruance SL. Efficacy of topical treatment for herpes simplex virus infections: predictions from an index of drug characteristics in vitro. J Infect Dis. 1986 Jan;153(1):64–70. [PubMed]
  • Harmenberg J. Intracellular pools of thymidine reduce the antiviral action of acyclovir. Intervirology. 1983;20(1):48–51. [PubMed]
  • Harmenberg J, Abele G, Malm M. Deoxythymidine pools in animal and human skin with reference to antiviral drugs. Arch Dermatol Res. 1985;277(5):402–403. [PubMed]
  • Harmenberg J, Wahren B, Sundqvist VA, Levén B. Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds. J Antimicrob Chemother. 1985 May;15(5):567–573. [PubMed]
  • Hubler WR, Jr, Felber TD, Troll D, Jarratt M. Guinea pig model for cutaneous herpes simplex virus infection. J Invest Dermatol. 1974 Feb;62(2):92–95. [PubMed]
  • Kinghorn GR, Turner EB, Barton IG, Potter CW, Burke CA, Fiddian AP. Efficacy of topical acyclovir cream in first and recurrent episodes of genital herpes. Antiviral Res. 1983 Dec;3(5-6):291–301. [PubMed]
  • Larsson A, Brännström G, Oberg B. Kinetic analysis in cell culture of the reversal of antiherpes activity of nucleoside analogs by thymidine. Antimicrob Agents Chemother. 1983 Nov;24(5):819–822. [PubMed]
  • Luby JP, Gnann JW, Jr, Alexander WJ, Hatcher VA, Friedman-Kien AE, Klein RJ, Keyserling H, Nahmias A, Mills J, Schachter J, et al. A collaborative study of patient-initiated treatment of recurrent genital herpes with topical acyclovir or placebo. J Infect Dis. 1984 Jul;150(1):1–6. [PubMed]
  • Oberg B. Antiviral effects of phosphonoformate (PFA, foscarnet sodium). Pharmacol Ther. 1982;19(3):387–415. [PubMed]
  • Reichman RC, Badger GJ, Guinan ME, Nahmias AJ, Keeney RE, Davis LG, Ashikaga T, Dolin R. Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial. J Infect Dis. 1983 Feb;147(2):336–340. [PubMed]
  • Spruance SL, Crumpacker CS, Schnipper LE, Kern ER, Marlowe S, Arndt KA, Overall JC., Jr Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir. Antimicrob Agents Chemother. 1984 May;25(5):553–555. [PubMed]
  • Spruance SL, Freeman DJ, Sheth NV. Comparison of topically applied 5-ethyl-2'-deoxyuridine and acyclovir in the treatment of cutaneous herpes simplex virus infection in guinea pigs. Antimicrob Agents Chemother. 1985 Jul;28(1):103–106. [PubMed]
  • Spruance SL, McKeough MB, Cardinal JR. Penetration of guinea pig skin by acyclovir in different vehicles and correlation with the efficacy of topical therapy of experimental cutaneous herpes simplex virus infection. Antimicrob Agents Chemother. 1984 Jan;25(1):10–15. [PubMed]
  • Spruance SL, Schnipper LE, Overall JC, Jr, Kern ER, Wester B, Modlin J, Wenerstrom G, Burton C, Arndt KA, Chiu GL, Crumpacker CS. Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol. J Infect Dis. 1982 Jul;146(1):85–90. [PubMed]
  • Van Vloten WA, Swart RN, Pot F. Topical acyclovir therapy in patients with recurrent orofacial herpes simplex infections. J Antimicrob Chemother. 1983 Sep;12 Suppl B:89–93. [PubMed]
  • Wallin J, Lernestedt JO, Ogenstad S, Lycke E. Topical treatment of recurrent genital herpes infections with foscarnet. Scand J Infect Dis. 1985;17(2):165–172. [PubMed]
  • Yeo JM, Fiddian AP. Acyclovir in the management of herpes labialis. J Antimicrob Chemother. 1983 Sep;12 Suppl B:95–103. [PubMed]